Literature DB >> 33223082

Advances in the Surgical Management of Epilepsy: Drug-Resistant Focal Epilepsy in the Adult Patient.

Gregory D Cascino1, Benjamin H Brinkmann2.   

Abstract

Pharmacoresistant seizures occur in nearly one-third of people with epilepsy. Medial temporal lobe and lesional epilepsy are the most favorable surgically remediable epileptic syndromes. Successful surgery may render the patient seizure-free, reduce antiseizure drug(s) adverse effects, improve quality of life, and decrease mortality. Surgical management should not be considered a procedure of "last resort." Despite the results of randomized controlled trials, surgery remains an underutilized treatment modality for patients with drug-resistant epilepsy (DRE). Important disparities affect patient referral and selection for surgical treatment. This article discusses the advances in surgical treatment of DRE in adults with focal seizures.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug-resistant; Epilepsy; Neuroimaging; Surgical treatment

Year:  2020        PMID: 33223082     DOI: 10.1016/j.ncl.2020.09.010

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  3 in total

1.  Resection of an occipital lobe epileptogenic network resulting in improvement of a visual field deficit: illustrative case.

Authors:  Alper Dincer; John Herendeen; Joel Oster; James Kryzanski
Journal:  J Neurosurg Case Lessons       Date:  2022-10-17

2.  Memory and executive functioning outcomes of selective amygdalohippocampectomy in patients with hippocampal sclerosis: A preliminary study in a developing country.

Authors:  Seyyedeh Somayyeh Moshir Estekhareh; Sajjad Saghebdoust; Reza Zare; Mohsen Aghaee Hakak; Bahram Ali Ghanbari Hashemabadi
Journal:  Surg Neurol Int       Date:  2022-04-22

3.  Lipid mediator n-3 docosapentaenoic acid-derived protectin D1 enhances synaptic inhibition of hippocampal principal neurons by interaction with a G-protein-coupled receptor.

Authors:  Apostolos Mikroulis; Marco Ledri; Gabriele Ruffolo; Eleonora Palma; Günther Sperk; Jesmond Dalli; Annamaria Vezzani; Merab Kokaia
Journal:  FASEB J       Date:  2022-03       Impact factor: 5.834

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.